Health Care

Stocks are moderately lower in midday trading Monday as the market drifts between small gains and losses.

Valeant Pharmaceuticals replaced Robert Rosiello as chief financial officer as the embattled company attempts to normalize operations amid a host of ongoing investigations and class action lawsuits.

Pfizer will pay about $14 billion in cash for the cancer drug company Medivation, a deal that will add the pricey late-stage prostate cancer treatment Xtandi to its oncology portfolio.

Pfizer will pay $81.50 a share, a 21% premium to Medivation's closing stock price Friday. Medivation shares traded up 20% to $80.47 in early trading as Pfizer shares fell 5 cents to $34.92.

Pfizer makes it official. The company is acquiring cancer drug company Medivation in a deal worth $14 billion

Immediately after the UK voted to leave the European Union, dealmakers thought they were dead in the water...

The insurer warned regulators last month that blocking its planned merger with Humana would force it to abandon the Obamacare exchanges, and now it's following through on its promise.

Aetna warned Justice Department antitrust officials in early July that if Humana deal was blocked, it would reduce its presence in the Affordable Care Act exchanges.

Aetna said that due to persistent financial losses on Obamacare plans, it will sell individual insurance on the government-run online marketplaces in only four states next year.

This year has seen large mergers including Comcast and Time Warner Cable fall apart, but it has not deterred other companies from combining. It is shaping up to be the year of the mega deal, with 2015 on track to break a record in big M&A.

Although not quite at dot com boom levels, the U.S. is seeing the most venture-backed IPOs since the tech bubble. Fifty-five companies with venture financing have priced this year, the most seen in the same period since 2000, when there were 148, according to Dealogic.

Although not quite at dot com boom levels, the U.S. is seeing the most venture-backed IPOs since the tech bubble. Fifty-five companies with venture financing have priced this year, the most seen in the same period since 2000, when there were 148, according to Dealogic.

The Microsoft co-founder and philanthropist discussed the software giant’s future and U.S. immigration policies in an exclusive interview with the FOX Business Network.